Why the study?
Does fetal cardiac arrhythmia increase the risk of adverse clinical outcomes compared to the general pregnant population?
Does fetal cardiac arrhythmia increase the risk of adverse clinical outcomes compared to the general pregnant population?
Fetuses with cardiac arrhythmia represent a high-risk group with significantly increased rates of congenital malformations, fetal distress, and perinatal/neonatal mortality, warranting intensified supervision.
Identifies fetal arrhythmia as a marker of elevated perinatal risk; leaves open whether enhanced surveillance improves outcomes.
In 113 cases of fetal cardiac arrhythmia, i.e. 94 with supraventricular arrhythmia, 5 with atrioventricular block and 14 with ventricular arrhythmia, the clinical outcome was studied and compared with the general pregnant population. The arrhythmia group was afflicted with a significantly increased frequency of congenital malformations, 6.2% vs. 2.0%; fetal distress in labor, 20.4% vs. 13.5%; perinatal mortality, 3.5% vs. 0.7%; and neonatal mortality, 1.8% vs. 0.1%. In 4 cases, pharmacological cardiac treatment was needed in utero due to fetal heart failure. Fetuses with cardiac arrhythmia thus constitute an obstetric and pediatric high-risk group that should be subjected to an intensified supervision to detect fetal heart failure or fetal distress. When indicated, these complications can be treated in utero.
No takes yet. Share an insight, caveat, or question.
Lingman et al. (1986) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: